Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Molecular Therapeutics Overview Sparkline Graph

Graph co-Publications by faculty members in Molecular Therapeutics

Show all Molecular Therapeutics members

Publications (total of 2183)

no pagination
Hensley H, Quinn BA, Wolf RL, Litwin SL, Mobuchi S, Williams SJ, Williams C, Hamilton TC, Connolly DC. Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer. Cancer Biology & Therapy. 2007 Nov;6(11):1717-25.
Narra K, Mullins SR, Lee HO, Strzemkowski-Brun B, Magalong K, Christiansen VJ, McKee PA, Egleston B, Cohen SJ, Weiner LM, Meropol NJ, Cheng JD. Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer. Cancer Biology & Therapy. 2007 Nov;6(11):1691-9.
Okawa T, Michaylira CZ, Kalabis J, Stairs DB, Nakagawa H, Andl CD, Johnstone CN, Klein-Szanto AJ, El-Deiry WS, Cukierman E, Herlyn M, Rustgi AK. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes & development. 2007 Nov;21(21):2788-803.
Willis AI, Ridge JA. Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies. Head & neck. 2007 Nov;29(11):979-85.
Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, Wong S, Ang K. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol. 2007 Oct 20;25(30):4800-5.
Denlinger CS, Cohen SJ. Progress in the development of prognostic and predictive markers for gastrointestinal malignancies. Current treatment options in oncology. 2007 Oct;8(5):339-51.
Hayes DF, Thor AD, Dressler LG, Weaver D, Edgerton S, Cowan D, Broadwater G, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA. HER2 and response to paclitaxel in node-positive breast cancer. New England Journal of Medicine. 2007 Oct;357(15):1496-506.
Konski AA, Cheng JD, Goldberg M, Li T, Maurer A, Yu JQ, Haluszka O, Scott W, Meropol NJ, Cohen SJ, Freedman G, Weiner LM. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2007 Oct;69(2):358-63.
Matthew EM, Yen TJ, Dicker DT, Dorsey JF, Yang WS, Navaraj A, El-Deiry WS. Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cells. Cell cycle (Georgetown, Tex). 2007 Oct;6(20):2571-8.
Murphy MJ, Balter J, Balter S, BenComo JA, Das IJ, Jiang SB, Ma CM, Olivera GH, Rodebaugh RF, Ruchala KJ, Shirato H, Yin FF. The management of imaging dose during image-guided radiotherapy: Report of the AAPM Task Group 75. Medical Physics. 2007 Oct;34(10):4041-63.
O'Grady MA, Gitelson E, Swaby RF, Goldstein LJ, Sein E, Keeley P, Miller B, Li T, Weinstein A, Cohen SJ. Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: the fox chase cancer center partners initiative. J Natl Compr Canc Netw. 2007 Oct;5(9):875-82.
O'Neill GM, Seo S, Serebriiskii HG, Lessin SR, Golemis EA. A new central scaffold for metastasis: Parsing HEF1le/Cas-L/NEDD9. Cancer Research. 2007 Oct;67(19):8975-9.
Samuel D, Cheng H, Riley PW, Canutescu AA, Nagaswami C, Weisel JW, Bu Z, Walsh PN, Roder H. Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation. Proceedings of the National Academy of Sciences of the United States of America. 2007 Oct;104(40):15693-8.
Bender GM, Lehmann A, Zou H, Cheng H, Fry HC, Engel D, Therien MJ, Blasie JK, Roder H, Saven JG, DeGrado WF. De novo design of a single-chain diphenylporphyrin metalloprotein. J Am Chem Soc. 2007 Sep 05;129(35):10732-40.
Freedman GM, Meropol NJ, Sigurdson ER. Phase I trial of preoperative hypofractionated intensity modulated radiation therapy (IMRT) with incorporated boost and oral capecitabine in locally advanced rectal cancer (vol 67, pg 651, 2007). International Journal of Radiation Oncology Biology Physics. 2007 Sep;69(1):320.
Kell MR, Ridge JA, Joseph N, Sigurdson ER. PET CT imaging in patients undergoing sentinel node biopsy for melanoma. Eur J Surg Oncol. 2007 Sep;33(7):911-3.
Snell WJ, Golemis EA. A ciliary timer for S-phase entry. Nature Reviews Molecular Cell Biology. 2007 Sep;.
Tang Y, Lou J, Alpaugh RK, Robinson MK, Marks JD, Weiner LM. Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen. J Immunol. 2007 Sep;179(5):2815-23.
Breen MS, Breen M, Butts K, Chen LL, Saidel GM, Wilson DL. MRI-guided thermal ablation therapy: Model and parameter estimates to predict cell death from MR thermometry images. Annals of Biomedical Engineering. 2007 Aug;35(8):1391-403.
Nordberg E, Friedman M, Gostring L, Adams GP, Brismar H, Nilsson FY, Stahl S, Glimelius B, Carlsson J. Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule. Nuclear Medicine and Biology. 2007 Aug;34(6):609-18.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications by faculty members in Molecular Therapeutics


Show All Units
Last updated on Monday, August 10, 2020